RhumbLine Advisers’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-45,516
| Closed | -$50.1K | – | 4139 |
|
|
2025
Q1 | $50.1K | Sell |
45,516
-7,560
| -14% | -$8.32K | ﹤0.01% | 3576 |
|
|
2024
Q4 | $91.3K | Sell |
53,076
-35,408
| -40% | -$60.9K | ﹤0.01% | 3502 |
|
|
2024
Q3 | $219K | Buy |
88,484
+36,161
| +69% | +$89.7K | ﹤0.01% | 3191 |
|
|
2024
Q2 | $127K | Buy |
+52,323
| New | +$127K | ﹤0.01% | 3438 |
|
|
2022
Q2 | – | Sell |
-20,273
| Closed | -$79K | – | 3085 |
|
|
2022
Q1 | $79K | Buy |
+20,273
| New | +$79K | ﹤0.01% | 2930 |
|